Overview

Clinical Trial to Examine the Pain Relief of PH-797804 Alone Or With Naproxen in Subjects With Osteoarthritis of the Knee

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
PH-797804 is a potent inhibitor of inflammatory mediators that have a potential role in pain signalling following nerve injury and inflammation. Blocking such mediators may potentially have a therapeutic benefit by reducing pain.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Naproxen